Diabetic obese mice treated with TAN at doses of 200 mg/kg experience reductions in body weight, insulin resistance and lowered secretion of key inflammation markers, adiponectin, leptin, resistin, IL‐6, and MCP‐1. This evidence concerns the gene RETN and Insulin resistance.